Genmab | Beneficio Operativo



Operating Profit Cambio Fecha
Agios Pharmaceuticals USD -106629000 18.41M 2025-03
Almirall EUR 43.02M 8.82M 2025-06
Amarin USD -16755000 35.77M 2025-03
Amgen USD 1.29B 1.02B 2025-03
argenx SE USD 138.94M 35.9M 2025-03
AstraZeneca USD 3.67B 1.64B 2025-03
Bayer EUR 2.32B 1.21B 2025-03
BioMarin Pharmaceutical USD 223.89M 62.49M 2025-03
Demant DKK 2.34B 1.32B 2024-12
Exelixis USD 186.86M 23.65M 2025-04
Fresenius Medical Care EUR 331M 72.1M 2025-03
Galapagos EUR -57027000 101.68M 2025-06
Genmab DKK 188M 2B 2025-03
GlaxoSmithKline GBP 2.22B 1.52B 2025-03
GN Store Nord DKK 215M 486M 2025-03
GRIFOLS EUR 268.86M 103M 2025-03
Hikma Pharmaceutical USD 282M 45M 2024-12
Insmed USD -248140000 17.73M 2025-03
Lonza CHF 430M 104M 2024-12
Merck EUR 1.01B 189M 2025-03
Novartis USD 4.86B 201M 2025-06
Regeneron Pharmaceuticals USD 591.7M 398.5M 2025-03
Roche Holding CHF 4.39B 1.04B 2024-12
Sanofi EUR 2.28B 1.42B 2025-03
UCB EUR 1B 678M 2024-12


Genmab Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Jul 2025.